• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

不同肝切除手术对术后患者循环肿瘤细胞的影响:一项病例匹配对照研究。

Effect of various hepatectomy procedures on circulating tumor cells in postoperative patients: a case-matched comparative study.

作者信息

Lei YongRong, Wang XiShu, Tian YiChen, Xu Rong, Pei Jun, Fu YuNa, Sun Heng, Wang YaNi, Zheng Ping, Xia Feng, Wang JianHua

机构信息

Key Laboratory of Biorheological Science and Technology (Ministry of Education), College of Bioengineering, Chongqing University, Chongqing, China.

Key Laboratory of Hepatobiliary and Pancreatic Surgery, Institute of Hepatobiliary Surgery, Southwest Hospital, Third Military Medical University (Army Medical University), Chongqing, China.

出版信息

Front Med (Lausanne). 2023 Sep 28;10:1209403. doi: 10.3389/fmed.2023.1209403. eCollection 2023.

DOI:10.3389/fmed.2023.1209403
PMID:37841010
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10568028/
Abstract

BACKGROUND

The objective of this study is to elucidate the prevalence of systemic circulating tumor cells (CTCs) prior to and following resection of hepatocellular carcinoma (HCC), and to compare the disparities in postoperative CTCs in terms of quantity and classifications between the open liver resection (OPEN) and laparoscopic liver resection (LAP) cohorts.

PATIENTS MATERIALS AND METHODS

From September 2015 to May 2022, 32 consecutive HCC patients who underwent laparoscopic liver resection at Southwest Hospital were retrospectively enrolled in this study. The clinicopathological data were retrieved from a prospectively collected computer database. Patients in the OPEN group matched at a 1:1 ratio with patients who underwent open liver resection during the study period on age, gender, tumor size, number of tumors, tumor location, hepatitis B surface antigen (HBsAg) positivity, alpha-fetoprotein (AFP) level, TNM and Child-Pugh staging from the database of patients to form the control group. The Can-Patrol CTC enrichment technique was used to enrich and classify CTCS based on epithelial-mesenchymal transformation phenotypes. The endpoint was disease-free survival (DFS), and the Kaplan-Meier method and multiple Cox proportional risk model were used to analyze the influence of clinicopathological factors such as total CTCs and CTC phenotype on prognosis.

RESULTS

The mean age of the 64 patients with primary liver cancer was 52.92 years (23-71), and 89.1% were male. The postoperative CTC clearance rate was more significant in the OPEN group. The total residual CTC and phenotypic CTC of the LAP group were significantly higher than those of the OPEN group ( = 0.017, 0.012, 0.049, and 0.030, respectively), which may increase the possibility of metastasis ( = 0.042). In Kaplan-Meier analysis, DFS was associated with several clinicopathological risk factors, including Barcelona Clinical Liver Cancer (BCLC) stage, tumor size, and vascular invasion. Of these analyses, BCLC Stage [ = 0.043, HR (95% CI) =2.03(1.022-4.034)], AFP [ = 0.007, HR (95% CI) =1.947 (1.238-3.062)], the number of positive CTCs [ = 0.004, HR (95% CI) =9.607 (2.085-44.269)] and vascular invasion [ = 0.046, HR (95% CI) =0.475 (0.22-1.023)] were significantly associated with DFS.

CONCLUSION

In comparison to conventional OPEN technology, LAP technology has the capacity to augment the quantity of epithelial, mixed, and mesenchymal circulating tumor cells (CTCs). Following the surgical procedure, there was a notable increase in the total CTCs, epithelial CTCs, and mixed CTCs within the LAP group, indicating a potential drawback of LAP in facilitating the release of CTCs.

摘要

背景

本研究的目的是阐明肝细胞癌(HCC)切除术前和术后全身循环肿瘤细胞(CTC)的患病率,并比较开放肝切除术(OPEN)和腹腔镜肝切除术(LAP)队列在术后CTC数量和分类方面的差异。

患者材料与方法

2015年9月至2022年5月,对西南医院连续32例行腹腔镜肝切除术的HCC患者进行回顾性研究。临床病理数据从前瞻性收集的计算机数据库中获取。OPEN组患者与研究期间接受开放肝切除术的患者按1:1比例匹配年龄、性别、肿瘤大小、肿瘤数量、肿瘤位置、乙肝表面抗原(HBsAg)阳性、甲胎蛋白(AFP)水平、TNM和Child-Pugh分期,组成对照组。采用Can-Patrol CTC富集技术,根据上皮-间质转化表型对CTCs进行富集和分类。终点为无病生存期(DFS),采用Kaplan-Meier法和多因素Cox比例风险模型分析总CTC和CTC表型等临床病理因素对预后的影响。

结果

64例原发性肝癌患者的平均年龄为52.92岁(23 - 71岁),男性占89.1%。OPEN组术后CTC清除率更显著。LAP组的总残留CTC和表型CTC均显著高于OPEN组(分别为=0.017、0.012、0.049和0.030),这可能增加转移的可能性(=0.042)。在Kaplan-Meier分析中,DFS与几个临床病理风险因素相关,包括巴塞罗那临床肝癌(BCLC)分期、肿瘤大小和血管侵犯。在这些分析中,BCLC分期[=0.043,HR(95%CI)=2.03(1.022 - 4.034)]、AFP[=0.007,HR(95%CI)=1.947(1.238 - 3.062)]、阳性CTC数量[=0.004,HR(95%CI)=9.607(2.085 - 44.269)]和血管侵犯[=0.046,HR(95%CI)=0.475(0.22 - 1.023)]与DFS显著相关。

结论

与传统的OPEN技术相比,LAP技术能够增加上皮、混合和间质循环肿瘤细胞(CTC)的数量。手术后,LAP组的总CTC、上皮CTC和混合CTC显著增加,表明LAP在促进CTC释放方面存在潜在缺陷。

相似文献

1
Effect of various hepatectomy procedures on circulating tumor cells in postoperative patients: a case-matched comparative study.不同肝切除手术对术后患者循环肿瘤细胞的影响:一项病例匹配对照研究。
Front Med (Lausanne). 2023 Sep 28;10:1209403. doi: 10.3389/fmed.2023.1209403. eCollection 2023.
2
Mesenchymal circulating tumor cells and Ki67: their mutual correlation and prognostic implications in hepatocellular carcinoma.间质循环肿瘤细胞和 Ki67:它们在肝细胞癌中的相互关系及其预后意义。
BMC Cancer. 2023 Jan 5;23(1):10. doi: 10.1186/s12885-023-10503-3.
3
Circulating Tumor Cell Phenotype Indicates Poor Survival and Recurrence After Surgery for Hepatocellular Carcinoma.循环肿瘤细胞表型预示着肝癌手术后生存和复发不良。
Dig Dis Sci. 2018 Sep;63(9):2373-2380. doi: 10.1007/s10620-018-5124-2. Epub 2018 Jun 21.
4
Diagnostic Value of Different Phenotype Circulating Tumor Cells in Hepatocellular Carcinoma.不同表型循环肿瘤细胞在肝细胞癌中的诊断价值。
J Gastrointest Surg. 2019 Dec;23(12):2354-2361. doi: 10.1007/s11605-018-04067-y. Epub 2019 Feb 25.
5
Significance of circulating tumor cells in the portal vein regarding metastases and vascular invasion in hepatocellular carcinoma patients.门静脉循环肿瘤细胞在肝细胞癌患者转移和血管侵犯方面的意义
J Gastrointest Oncol. 2021 Dec;12(6):3050-3060. doi: 10.21037/jgo-21-734.
6
Circulating tumor cells and CXCR4 in the prognosis of hepatocellular carcinoma.循环肿瘤细胞和CXCR4在肝细胞癌预后中的作用
Transl Cancer Res. 2020 Mar;9(3):1384-1394. doi: 10.21037/tcr.2020.01.14.
7
Association of Preoperative NANOG-Positive Circulating Tumor Cell Levels With Recurrence of Hepatocellular Carcinoma.术前NANOG阳性循环肿瘤细胞水平与肝细胞癌复发的相关性
Front Oncol. 2021 May 27;11:601668. doi: 10.3389/fonc.2021.601668. eCollection 2021.
8
Circulating stem cell-like epithelial cell adhesion molecule-positive tumor cells indicate poor prognosis of hepatocellular carcinoma after curative resection.循环干细胞样上皮细胞黏附分子阳性肿瘤细胞预示肝癌根治性切除术后不良预后。
Hepatology. 2013 Apr;57(4):1458-68. doi: 10.1002/hep.26151. Epub 2013 Mar 4.
9
The mesenchymal circulating tumor cells as biomarker for prognosis prediction and supervision in hepatocellular carcinoma.间质循环肿瘤细胞作为肝细胞癌预后预测和监测的生物标志物。
J Cancer Res Clin Oncol. 2023 Aug;149(9):6035-6048. doi: 10.1007/s00432-022-04526-9. Epub 2023 Jan 12.
10
Preoperative circulating tumor cells to predict microvascular invasion and dynamical detection indicate the prognosis of hepatocellular carcinoma.术前循环肿瘤细胞预测微血管侵犯和动态检测可预测肝细胞癌的预后。
BMC Cancer. 2020 Oct 31;20(1):1047. doi: 10.1186/s12885-020-07488-8.

本文引用的文献

1
Circulating Cell-Free Nucleic Acids as Biomarkers for Diagnosis and Prognosis of Pancreatic Cancer.循环游离核酸作为胰腺癌诊断和预后的生物标志物
Biomedicines. 2023 Apr 1;11(4):1069. doi: 10.3390/biomedicines11041069.
2
Detection and Molecular Characterization of Circulating Tumour Cells: Challenges for the Clinical Setting.循环肿瘤细胞的检测与分子特征分析:临床环境面临的挑战
Cancers (Basel). 2023 Apr 6;15(7):2185. doi: 10.3390/cancers15072185.
3
Circulating tumor cell associated white blood cell cluster as a biomarker for metastasis and recurrence in hepatocellular carcinoma.
循环肿瘤细胞相关白细胞簇作为肝细胞癌转移和复发的生物标志物
Front Oncol. 2022 Nov 17;12:931140. doi: 10.3389/fonc.2022.931140. eCollection 2022.
4
FOXD1-dependent RalA-ANXA2-Src complex promotes CTC formation in breast cancer.FOXD1 依赖性 RalA-ANXA2-Src 复合物促进乳腺癌的 CTC 形成。
J Exp Clin Cancer Res. 2022 Oct 13;41(1):301. doi: 10.1186/s13046-022-02504-0.
5
Single-incision laparoscopic surgery to treat hepatopancreatobiliary cancer: A technical review.单孔腹腔镜手术治疗肝胆胰恶性肿瘤:技术综述。
World J Gastroenterol. 2022 Jul 21;28(27):3359-3369. doi: 10.3748/wjg.v28.i27.3359.
6
Liquid biopsy: current technology and clinical applications.液体活检:当前技术与临床应用。
J Hematol Oncol. 2022 Sep 12;15(1):131. doi: 10.1186/s13045-022-01351-y.
7
Is liquid biopsy the future commutator of decision-making in liver transplantation for hepatocellular carcinoma?液体活检会成为肝细胞癌肝移植决策的未来转向器吗?
Front Oncol. 2022 Aug 11;12:940473. doi: 10.3389/fonc.2022.940473. eCollection 2022.
8
Laparoscopic versus open liver resection for hepatocellular carcinoma in elderly patients: Systematic review and meta-analysis of propensity-score matched studies.腹腔镜与开腹肝切除术治疗老年肝细胞癌的系统评价和倾向评分匹配研究的荟萃分析。
Int J Surg. 2022 Sep;105:106821. doi: 10.1016/j.ijsu.2022.106821. Epub 2022 Aug 7.
9
Uncovering the Heterogeneity and Clinical Relevance of Circulating Tumor-Initiating Cells in Hepatocellular Carcinoma Using an Integrated Immunomagnetic-Microfluidic Platform.利用集成免疫磁珠-微流控平台揭示肝癌中循环肿瘤起始细胞的异质性和临床相关性。
ACS Appl Mater Interfaces. 2022 Aug 17;14(32):36425-36437. doi: 10.1021/acsami.2c09085. Epub 2022 Aug 2.
10
Circulating tumor cells in precision medicine: challenges and opportunities.循环肿瘤细胞在精准医学中的应用:挑战与机遇。
Trends Pharmacol Sci. 2022 May;43(5):378-391. doi: 10.1016/j.tips.2022.02.005. Epub 2022 Mar 7.